Exceptional response to cetuximab monotherapy in a patient with metastatic oropharyngeal squamous cell carcinoma: a molecular insight

Exceptional response to cetuximab monotherapy in a patient with metastatic oropharyngeal squamous cell carcinoma: a molecular insight

Prakash Peddi,1 Bhavna Paryani,2 Amol Takalkar,2 Paige Bundrick,3 John Ponugupati,4 Binu Nair,5 Hazem El-Osta1 1Department of Medicine, Division of Hematology-Oncology, 2Department of Radiology, 3Department of Head and Neck Surgery, Louisiana State University Health Sciences Center, Shreveport, LA,...

Full description

Bibliographic Details
Main Authors: Peddi P, Paryani B, Takalkar A, Bundrick P, Ponugupati J, Nair B, El-Osta H
Format: Article
Language:English
Published: Dove Medical Press 2016-02-01
Series:OncoTargets and Therapy
Subjects:
biomarker
cetuximab
EGFR blockade
exceptional response
and head and neck squamous cell carcinoma
Online Access:https://www.dovepress.com/exceptional-response-to-cetuximab-monotherapy-in-a-patient-with-metast-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/exceptional-response-to-cetuximab-monotherapy-in-a-patient-with-metast-peer-reviewed-article-OTT

Similar Items